Recruiting Myelofibrosis Studies in Whittier
KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment
This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the treatment of patients with myelofibrosis (MF) who no longer benefit from treatment with a JAK inhibitor. Inhibition...
Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis
This study evaluates either KRT-232 or TL-895 in treatment naïve patients with myelofibrosis (MF) The study will be conducted in 2 stages. Stage 1 will evaluate safety, tolerability, and efficacy of ...
About Myelofibrosis Clinical Trials in Whittier
Myelofibrosis is a serious bone marrow disorder that disrupts normal blood cell production, leading to extensive scarring in the bone marrow. It can cause severe anemia, weakness, and an enlarged spleen. Treatment includes JAK inhibitors, blood transfusions, and stem cell transplant.
There are currently 2 myelofibrosis clinical trials recruiting participants in Whittier, CALIFORNIA. These studies are seeking a combined 437 participants. Research is being sponsored by Kartos Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myelofibrosis Clinical Trials in Whittier — FAQ
Are there myelofibrosis clinical trials in Whittier?
Yes, there are 2 myelofibrosis clinical trials currently recruiting in Whittier, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Whittier?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Whittier research site will contact you about next steps.
Are clinical trials in Whittier free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Whittier studies also compensate for your time and travel.
What myelofibrosis treatments are being tested?
The 2 active trials in Whittier are testing new therapies including novel drugs, biologics, and treatment approaches for myelofibrosis.
Data updated March 2, 2026 from ClinicalTrials.gov